NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.19 Cr | ₹-7.43 Cr | ₹7.18 Cr | ₹-1.46 Cr | ₹1.70 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NGL FINECHEM ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.19 Cr |
| Mar2024 | ₹-7.43 Cr |
| Mar2023 | ₹7.18 Cr |
| Mar2022 | ₹-1.46 Cr |
| Mar2021 | ₹1.70 Cr |
How is Net Cash Inflow / Outflow of NGL FINECHEM Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.19 Cr | Positive | |
| Mar2024 | ₹-7.43 Cr | Negative | |
| Mar2023 | ₹7.18 Cr | Positive | |
| Mar2022 | ₹-1.46 Cr | Negative | |
| Mar2021 | ₹1.70 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,907.9 Cr | 5.1% | 11.1% | 204.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 5.1% |
11.1% |
204.7% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses